Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.01.027
Abstract: Ticagrelor is a nonthienopyridine direct and reversible P2Y12 platelet receptor antagonist, and unlike prasugrel or clopidogrel inhibits, at least partially, the sodium-independent equilibrative nucleoside transporter 1 [(1)][1]. This ticagrelor-mediated off-target effect has potential to improve read more here.
Keywords: prasugrel; clopidogrel steady; prasugrel clopidogrel; ticagrelor prasugrel ... See more keywords